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1. Introduction 
Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) is gaining wider use for 
patients with coronary artery disease. The procedures are challenging technically [1] and require a 
long learning curve, longer procedural times, and greater contrast volume use and radiation exposure, 
as well as more use of materials than conventional PCI. Therefore, patient selection for 
revascularization would be of utmost importance in CTO-PCI. Assessment of myocardial viability 
before revascularization is crucial, as the benefit of CTO revascularization depends on the presence or 
absence of myocardial viability of CTO territory. The opening of an occluded coronary artery that 
supplies a viable but dysfunctional myocardium could recover systolic dysfunction, relieve patients’ 
symptoms and improve their outcomes [2]. However, limited data are available regarding the 
prediction for functional recovery using late gadolinium enhanced magnetic resonance imaging (LGE 
MRI) after CTO-PCI. The objectives of this study were to explore the optimal cut-off value of 
transmural extent of LGE MRI for functional recovery in terms of myocardial strains after CTO 
revascularization and to evaluate the benefit of using MRI and 2-dimensional speckle-tracking 
echocardiography for analyzing CTO revascularization. Meanwhile, among patients treated with 
CTO-PCI, patients on chronic hemodialysis (HD) are at significantly high risk for cardiovascular 
mortality and morbidity [3]. However, clinical or angiographic predictors that might aid in better 
patient selection remain unclear. We aimed to assess the acute impact of HD in patients who underwent 
CTO-PCI. 
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2. Methods and results 
We studied 59 patients (mean age, 66±11 years) who underwent successful CTO-PCI. Two-
dimensional echocardiography and strain measurements were performed before and 8±2 months after 
CTO-PCI. The findings of segmental assessment were compared with the extent of LGE MRI using a 
16-segment model. From baseline to follow-up, ejection fraction (54.2±12.1% to 56.1±10.6%, P = 
0.010), global longitudinal strain (LS) (-15.1±5.1 to -16.7±5.1, P < 0.001), global circumferential 
strain (CS) (-14.0±4.9 to -15.9±4.9, P < 0.001), and wall motion score (WMS) index (1.45±0.53 to 
1.33±0.39, P = 0.014) significantly improved. In the territory of the CTO vessel, LS and CS 
significantly improved in segments of LGE ≤50%, but not in segments of LGE >50% (Figure 1). 
However, WMS improved only in segments of LGE 1% to 25%. At baseline and at follow-up, CS 
allowed better discrimination of segments of LGE >50% than WMS (at baseline; area under the curve 
0.79 vs. 0.68, respectively, P = 0.001: at follow-up; area under the curve 0.84 vs. 0.69, respectively, P 
< 0.001). Discriminatory ability of LS for segments of LGE >50% significantly improved from 
baseline to follow-up (area under the curve 0.73 vs. 0.83, P < 0.001).  
The Retrograde Summit registry is a multicenter, prospective registry of patients undergoing CTO-
PCI at 65 Japanese centers. Patient characteristics and procedural outcomes of 4749 patients were 
analyzed, according to the presence (n = 313) or absence (n = 4436) of baseline HD. A prediction 
model for technical failure among HD patients was also developed. The technical success rate of CTO-
PCI was significantly lower in HD than in non-HD patients (78.0% vs. 89.1%, P < 0.001). The rates 
of in-hospital major adverse cardiac and cerebrovascular events were similar between the two groups 
(1.6% vs. 0.9%, P = 0.24). Irrespective of clinical/angiographic characteristics or previously 
developed scoring systems, HD independently predicted technical failure for CTO-PCI. Among HD 
patients, predictors of technical failure were blunt stump (odds ratio 2.45, 95% confidence interval 
1.15 to 5.21, P = 0.021), severe lesion calcification (odds ratio 2.50, 95% confidence interval 1.19 to 
5.24, P = 0.015), and absence of diabetes mellitus (odds ratio 3.15, 95% confidence interval 1.49 to 
6.64, P = 0.003). In HD patients without these predictors, the technical success rate was 96.2% (Figure 
2). 
 
3. Discussion 
The cut-off value of the extent of LGE MRI is 50% to detect segments that will functionally recover 
after CTO-PCI. Change in LS was more sensitive for removal of ischemia by CTO-PCI, indicating the 
utility of LS to monitor the therapeutic effects of CTO recanalization. 
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HD is significantly associated with technical failure. Contemporary CTO-PCI seems feasible and safe 
in selected HD patients. 
With regard to CTO-PCI, improvement in patient selection would contribute to a higher technical 
success rate, greater prognostic advantage, and wider use of complex PCI with dedicated devices and 
specialized techniques. 
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